The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-24
DOI
10.3389/fonc.2019.00952
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study
- (2018) C K Y Ng et al. ANNALS OF ONCOLOGY
- Somatic evolutionary timings of driver mutations
- (2018) Karen Gomez et al. BMC CANCER
- Next-generation sequencing technologies and their application to the study and control of bacterial infections
- (2018) J. Besser et al. CLINICAL MICROBIOLOGY AND INFECTION
- Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics
- (2018) Sadakatsu Ikeda et al. MOLECULAR CANCER THERAPEUTICS
- Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
- (2018) Sadakatsu Ikeda et al. ONCOLOGIST
- Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma
- (2018) Tatsunori Miyata et al. Oncotarget
- KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
- (2018) Francesco Sclafani et al. Scientific Reports
- Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
- (2018) Xiangchun Li et al. Theranostics
- Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
- (2018) Nerino Allocati et al. Oncogenesis
- Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests
- (2018) Gonzalo Torga et al. JAMA Oncology
- ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
- (2018) Martin H.D. Neumann et al. Computational and Structural Biotechnology Journal
- Liquid biopsies for management of pancreatic cancer
- (2018) Mohamadmahdi Samandari et al. Translational Research
- Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
- (2017) He Cheng et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
- (2017) Mohammad Khan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Comparison of Cell-Free DNA Isolation Kits
- (2017) Laure Sorber et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
- (2017) Rui-hua Xu et al. NATURE MATERIALS
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review
- (2017) Kensuke Yamamura et al. SURGERY TODAY
- Survival of pancreatic cancer cells lacking KRAS function
- (2017) Mandar Deepak Muzumdar et al. Nature Communications
- Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
- (2017) Eveline E. Vietsch et al. Cancer Genetics
- Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
- (2017) Inna Chen et al. Oncotarget
- Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
- (2017) Andreas W. Berger et al. Oncotarget
- Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines
- (2017) Wei Wang et al. Oncotarget
- Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis
- (2017) Ruifang Mao et al. Oncotarget
- Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2017) Nader N. Massarweh et al. Cancer Control
- Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
- (2017) Yi Chang et al. Therapeutics and Clinical Risk Management
- Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
- (2017) An Tang et al. Abdominal Radiology
- The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
- (2017) Sunjida Ahmed et al. Journal of Clinical Medicine
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
- (2017) Jonas Cicenas et al. Cancers
- Characterization of the cell-free DNA released by cultured cancer cells
- (2016) Abel Jacobus Bronkhorst et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
- (2016) Eliana Amato et al. BMC CANCER
- Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
- (2016) Naoto Hadano et al. BRITISH JOURNAL OF CANCER
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer
- (2016) Chinthalapally V. Rao et al. CARCINOGENESIS
- Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
- (2016) Jun Yu et al. GUT
- Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
- (2016) Yang Gao et al. International Journal of Medical Sciences
- Genotype-Phenotype Correlation of CTNNB1 Mutations Reveals Different B-Catenin Activation Levels in Hepatocellular Tumors with High Activity Associated with Malignancy
- (2016) S. Rebouissou et al. JOURNAL OF HEPATOLOGY
- Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis
- (2016) Xing Shugang et al. Translational Oncology
- Genetic alterations in hepatocellular carcinoma: An update
- (2016) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic Cancer Epidemiology, Detection, and Management
- (2016) Qiubo Zhang et al. Gastroenterology Research and Practice
- Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
- (2016) Massimiliano Berretta et al. Oncotarget
- Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
- (2016) Wenjun Liao et al. Oncotarget
- Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
- (2016) Ao Huang et al. Journal of Cancer
- Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients
- (2015) Lu Wen et al. CELL RESEARCH
- Cell-free DNA: Preanalytical variables
- (2015) Abel Jacobus Bronkhorst et al. CLINICA CHIMICA ACTA
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Mutation of theTERTpromoter, switch to active chromatin, and monoallelicTERTexpression in multiple cancers
- (2015) Josh Lewis Stern et al. GENES & DEVELOPMENT
- Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
- (2015) Kjersti Tjensvoll et al. Molecular Oncology
- Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
- (2015) R. M. Perera et al. Cancer Discovery
- The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
- (2015) Nicolas Skrypek et al. Oncotarget
- Targeted sequencing with enrichment PCR: a novel diagnostic method for the detection of EGFR mutations
- (2015) Suki Kang et al. Oncotarget
- SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma
- (2015) Yeon-Su Lee et al. Oncotarget
- Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing
- (2015) Hongtao Xu et al. Journal of Cancer
- Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
- (2015) Erina Takai et al. Scientific Reports
- LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas
- (2014) Kazuto Harada et al. ANNALS OF SURGICAL ONCOLOGY
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- The Hippo pathway in chemotherapeutic drug resistance
- (2014) Yulei Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Hurdles on the road to personalized medicine
- (2014) Thomas Tursz et al. Molecular Oncology
- Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
- (2014) Chaitanya R. Churi et al. PLoS One
- What is next generation sequencing?
- (2013) Sam Behjati et al. Archives of Disease in Childhood-Education and Practice Edition
- Circulating free DNA in the progression of liver damage to hepatocellular carcinoma
- (2013) Marika Piciocchi et al. Hepatology International
- Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
- (2013) Ellen Heitzer et al. INTERNATIONAL JOURNAL OF CANCER
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
- (2013) K. C. A. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Clinical and molecular characterization of HER2 amplified-pancreatic cancer
- (2013) Angela Chou et al. Genome Medicine
- Detection ofTP53R249 Mutation in Iranian Patients with Pancreatic Cancer
- (2013) Ashraf Mohamadkhani et al. Journal of Oncology
- A Missing Link in Genotype-Directed Cancer Therapy
- (2012) René Bernards CELL
- Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer
- (2012) Stephen P. Malkoski et al. FEBS LETTERS
- Nucleic acids in circulation: Are they harmful to the host?
- (2012) Indraneel Mittra et al. JOURNAL OF BIOSCIENCES
- The Predictive Role of p16 Deletion, p53 Deletion, and Polysomy 9 and 17 in Pancreatic Ductal Adenocarcinoma
- (2012) Yanli Luo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Impact of the Location of CpG Methylation within the GSTP1 Gene on Its Specificity as a DNA Marker for Hepatocellular Carcinoma
- (2012) Surbhi Jain et al. PLoS One
- A rare point mutation in the Ras oncogene in hepatocellular carcinoma
- (2012) Akinobu Taketomi et al. SURGERY TODAY
- Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification
- (2011) Leonardo B. Pinheiro et al. ANALYTICAL CHEMISTRY
- Origin, translocation and destination of extracellular occurring DNA — A new paradigm in genetic behaviour
- (2011) Dimetrie L. Peters et al. CLINICA CHIMICA ACTA
- The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer
- (2011) Kenneth D. Tew et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cellular senescence and tumor suppressor gene p16
- (2011) Hani Rayess et al. INTERNATIONAL JOURNAL OF CANCER
- The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
- (2011) Nardin Samuel et al. Nature Reviews Gastroenterology & Hepatology
- High Fragmentation Characterizes Tumour-Derived Circulating DNA
- (2011) Florent Mouliere et al. PLoS One
- Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
- (2010) Antal Csepregi et al. BMC CANCER
- Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
- (2010) D. C. Garcia-Olmo et al. CANCER RESEARCH
- Single-Tube Analysis of DNA Methylation with Silica Superparamagnetic Beads
- (2010) V. J. Bailey et al. CLINICAL CHEMISTRY
- K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer
- (2010) H. Chen et al. EJSO
- Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling
- (2010) Robert R McWilliams et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- HER2 overexpression correlates with survival after curative resection of pancreatic cancer
- (2009) Masahiro Komoto et al. CANCER SCIENCE
- Tumor Suppressive Functions of p53
- (2009) J. T. Zilfou et al. Cold Spring Harbor Perspectives in Biology
- Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases
- (2008) Gihan Hosny et al. CANCER LETTERS
- Unequal representation of different unique genomic DNA sequences in the cell-free plasma DNA of individual donors
- (2008) William M. Puszyk et al. CLINICAL BIOCHEMISTRY
- Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma
- (2008) K. C. A. Chan et al. CLINICAL CHEMISTRY
- Pancreatic Cancer Development and Progression: Remodeling the Model
- (2008) Francisco X. Real et al. GASTROENTEROLOGY
- Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver
- (2008) Jan Harder et al. INTERNATIONAL JOURNAL OF CANCER
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Characterization of circulating DNA in healthy human plasma
- (2007) Nobuyasu Suzuki et al. CLINICA CHIMICA ACTA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now